Cardiomyopathy CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Lina Ya'qoub, MD ; Edzel Lorraine Co, DMD, MD[2]

Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines

2023 ESC Guideline Recommendations

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Case Studies

Case #1

Cardiomyopathy CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiomyopathy CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomyopathy CT

CDC on Cardiomyopathy CT

Cardiomyopathy CT in the news

Blogs on Cardiomyopathy CT

Directions to Hospitals Treating Cardiomyopathy

Risk calculators and risk factors for Cardiomyopathy CT

## Overview[edit | edit source]

Cardiac CT has been increasingly recognized as a tool to assess for ischemic heart disease in those with intermediate pre-test probability for coronary artery disease. Cardiac CT can identify calcifications and blockages in the coronary vessels. It may also detect associated cardiac anomalies. It mainly help to detect cardiomyopathies associated with coronary artery disease. CT is also useful to characterize of cardiomyopathy features, assessing cardiac volumes and heart function, and post-treatment evaluation. It is mostly useful in patients with pacemakers who can not undergo MRI for further evaluation of cardiomyopathies.

## Cardiomyopathy CT[edit | edit source]

* Cardiac CT has been increasingly recognized as a tool to assess for ischemic heart disease in those with intermediate pre-test probability for coronary artery disease. [1][2]
* Cardiac CT can identify calcifications and blockages in the coronary vessels.
* It may also detect associated cardiac anomalies. It mainly help to detect cardiomyopathies associated with coronary artery disease.
* CT is also useful to:
* Characterize of cardiomyopathy features
* Assessing cardiac volumes and heart function
* Post-treatment evaluation
* It is mostly useful in patients with pacemakers who can not undergo MRI for further evaluation of cardiomyopathies.

## References[edit | edit source]

1. ↑ Divakaran S, Cheezum MK, Hulten EA, Bittencourt MS, Silverman MG, Nasir K, Blankstein R (February 2015). "Use of cardiac CT and calcium scoring for detecting coronary plaque: implications on prognosis and patient management". Br J Radiol. 88 (1046): 20140594. doi:10.1259/bjr.20140594. PMC 4614250. PMID 25494818.
2. ↑ Kalisz K, Rajiah P (October 2017). "Computed tomography of cardiomyopathies". Cardiovasc Diagn Ther. 7 (5): 539–556. doi:10.21037/cdt.2017.09.07. PMC 5716950. PMID 29255695.

Template:WH Template:WS